adenovirus-mediated human interleukin-12
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2005 (NCT00301106)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Interleukin-12 subunit betaSupplementation
IL12B supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- adenovirus-mediated human interleukin-12
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00849459 | Phase 1 | Aug 1, 2008 | Icahn School of Medicine at Mount Sinai |
| NCT00301106 | Phase 1 | Oct 1, 2005 | Icahn School of Medicine at Mount Sinai |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 2 | 2 | 1 | 2005 |
1 organizations
Page 1 / 1